Overview
The purpose of this study is to evaluate long-term effectiveness and safety of patients with coronary disease treated with drug eluting balloon in real world practice.
Eligibility
Inclusion Criteria:
- After pre dilatation residual stenosis 30% and less and also without vessel dissection interrupted blood flow
- Age 20 and more
- Treated with Balloon angioplasty
- Signed informed consent and agreed to follow protocol
Exclusion Criteria:
- Allergy to paclitaxel, antiplatelet
- History of side effect to heparin, aspirin, thienopyridines
- History of bleeding tendency, coagulation disorder, blood transfusion reaction